RE: New major shareholder11 Jan 2022 11:57
your right BB2 just with the holdings rns today rang up on my radar so been doing some more digging on ICD (now we know who the other offtake partner was in the Feb 2018 rns) and Wolfram now it seems customers are investing in wres
Particularly interesting is the bit about CONFLICT FREE sourcing Dodd Frank Act, section 1502
ICD website
At ICD Group, we are proud to source our products from diverse, far-off locations across the globe. But while our specialized commodity products may be exotic, we are still human, which is why our materials are never sourced from Conflict Affected and High-Risk Areas (CAHRAs) as outlined by OECD. We are constantly adapting to evolving global conditions to ensure we comply with these self-imposed guidelines. To ensure adherence, ICD Group is frequently audited in terms of traceability of our products. We operate with full transparency so our customers can be confident our products are ethically sourced from regions free of conflict and major human right violations.
Wolfram website
Our company is a pioneer in the area of proven conflict-free raw material supply in the tungsten industry. We are in constant contact with relevant organisations (OECD, Conflict Free Sourcing Initiative (CFSI), EU), and we are a founding member of the Tungsten Industry – Conflict Mineral Council (TI-CMC) and a member of the ITRI Tin Supply Chain Initiative (iTSCi). The latter provides a traceability mechanism to trace the way of concentrates from the mines to our smelting plant. Annual audits by independent auditors on behalf of the CFSI demonstrate our responsible purchasing policy as Conflict Free Smelter.
This could mean other customers including Wolfram are not invested in Wres but ICD is now and if they carry on increasing their holding other future offtake agreements could be affected pushing up prices etc...